New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial.
Joao Pedro FerreiraJohn G ClelandCarolyn S P LamStefan D AnkerMandeep R MehraDirk J van VeldhuisenWilliam M ByraDavid A LaPoliceBarry GreenbergFaiez ZannadPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)
A well-calibrated risk-score identified patients at risk of new-onset AF in the COMMANDER-HF trial. Patients who developed AF had a higher risk of subsequent death. Risk of new-onset atrial fibrillation in patients with HFrEF and coronary artery disease.
Keyphrases
- atrial fibrillation
- coronary artery disease
- heart failure
- percutaneous coronary intervention
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- phase iii
- acute heart failure
- study protocol
- direct oral anticoagulants
- phase ii
- clinical trial
- coronary artery bypass grafting
- cardiovascular events
- randomized controlled trial
- open label
- cardiovascular disease
- left ventricular
- aortic valve
- mitral valve
- transcatheter aortic valve replacement